Vanda Pharmaceuticals(VNDA) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results WASHINGTON – July 31, 2025 – Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the second quarter ended June 30, 2025. "We have witnessed accelerated growth of Fanapt revenue coinciding with the expansion of our sales efforts alongside a broad direct to consumer brand awareness campaign and we expect this trend to continue in the coming quarters," said Mihael H. Polymeropoul ...